Open main menu

Oldest pages

Showing below up to 50 results in range #391 to #440.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Reference bioassay function‏‎ (13:51, 13 September 2019)
  2. Reference biokinetic model‏‎ (13:52, 13 September 2019)
  3. Reference level‏‎ (13:52, 13 September 2019)
  4. Rehabilitation of living conditions‏‎ (13:52, 13 September 2019)
  5. Relocation‏‎ (13:53, 13 September 2019)
  6. Remedial action‏‎ (13:53, 13 September 2019)
  7. Remediation‏‎ (13:53, 13 September 2019)
  8. Repopulation‏‎ (13:54, 13 September 2019)
  9. Representative organism (non-human biota)‏‎ (13:54, 13 September 2019)
  10. Representative person‏‎ (13:54, 13 September 2019)
  11. Reproductive integrity‏‎ (13:55, 13 September 2019)
  12. Residual dose‏‎ (13:55, 13 September 2019)
  13. Respiratory protection‏‎ (13:55, 13 September 2019)
  14. Retrievability‏‎ (13:56, 13 September 2019)
  15. Reversibility‏‎ (13:56, 13 September 2019)
  16. Right to know‏‎ (13:57, 13 September 2019)
  17. Rigidity‏‎ (13:58, 13 September 2019)
  18. Routine monitoring‏‎ (13:58, 13 September 2019)
  19. Safety case‏‎ (13:59, 13 September 2019)
  20. Safety culture‏‎ (13:59, 13 September 2019)
  21. Scintigraphy‏‎ (13:59, 13 September 2019)
  22. Self-help protection‏‎ (14:00, 13 September 2019)
  23. Slow repair‏‎ (14:01, 13 September 2019)
  24. Solar cosmic radiation‏‎ (14:01, 13 September 2019)
  25. Solar cycle‏‎ (14:01, 13 September 2019)
  26. Solar particle event‏‎ (14:01, 13 September 2019)
  27. Source term‏‎ (14:02, 13 September 2019)
  28. Source-related‏‎ (14:02, 13 September 2019)
  29. South Atlantic anomaly‏‎ (14:03, 13 September 2019)
  30. Special (non-routine) monitoring‏‎ (14:03, 13 September 2019)
  31. Spontaneous fission‏‎ (14:03, 13 September 2019)
  32. Stakeholder‏‎ (14:04, 13 September 2019)
  33. Stenosis‏‎ (14:04, 13 September 2019)
  34. Storage‏‎ (14:04, 13 September 2019)
  35. Subcutaneous tissue‏‎ (14:05, 13 September 2019)
  36. Substantial radiation dose level‏‎ (14:05, 13 September 2019)
  37. Systemic model‏‎ (14:06, 13 September 2019)
  38. Tachycardia‏‎ (14:10, 13 September 2019)
  39. Target region‏‎ (14:10, 13 September 2019)
  40. Target tissue‏‎ (14:10, 13 September 2019)
  41. Telangiectasia‏‎ (14:11, 13 September 2019)
  42. Threshold dose for tissue reactions‏‎ (14:11, 13 September 2019)
  43. Thyroid blocking‏‎ (14:11, 13 September 2019)
  44. Time factor‏‎ (14:11, 13 September 2019)
  45. Tissue equivalent material‏‎ (14:12, 13 September 2019)
  46. Tolerability‏‎ (14:12, 13 September 2019)
  47. Track structure‏‎ (14:13, 13 September 2019)
  48. Transfer compartment‏‎ (14:14, 13 September 2019)
  49. Transfer rate‏‎ (14:14, 13 September 2019)
  50. Transforming growth factor‏‎ (14:15, 13 September 2019)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)